Florence aims to simplify clinical trial documents through their electronic workflow software.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/22/2022 | Series C-1 | $16.36MM | $xx.xx | $339.88MM | Insight Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,484,070
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Insight Partners
|
||||||
06/22/2022 | Series C-1A | $10.64MM | $xx.xx | $339.88MM | Insight Partners | |
Price per Share
$xx.xx
Shares Outstanding
965,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Insight Partners
|
||||||
05/06/2021 | Series C | $84.4MM | $xx.xx | $176.81MM | Bee Partners, Flashpoint, Fulcrum Equity Partners, Insight Partners | |
Price per Share
$xx.xx
Shares Outstanding
14,200,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bee Partners, Flashpoint, Fulcrum Equity Partners, Insight Partners
|
||||||
10/10/2019 | Series A-2 | $1.03MM | $xx.xx | $8.34MM | Atrium Health, Bee Partners, Fulcrum Equity Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,347,980
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Atrium Health, Bee Partners, Fulcrum Equity Partners
|
||||||
10/10/2019 | Series A-3 | $264,147.30 | $xx.xx | $8.34MM | Atrium Health, Bee Partners, Fulcrum Equity Partners | |
Price per Share
$xx.xx
Shares Outstanding
231,100
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Atrium Health, Bee Partners, Fulcrum Equity Partners
|
||||||
08/03/2016 | Series A-4 | $94,996.00 | $xx.xx | $2.63MM | Bee Partners, Bessemer Venture Partners, Green D Fund, Will Crawford | |
Price per Share
$xx.xx
Shares Outstanding
374,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bee Partners, Bessemer Venture Partners, Green D Fund, Will Crawford
|
||||||
08/03/2016 | Series A-1 | $754,822.35 | $xx.xx | $2.63MM | Bee Partners, Bessemer Venture Partners, Green D Fund, Will Crawford | |
Price per Share
$xx.xx
Shares Outstanding
1,696,230
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bee Partners, Bessemer Venture Partners, Green D Fund, Will Crawford
|